Amended PREVAIL Act Advances Out Of Senate Judiciary, But Updates Possible

By Gabrielle Wanneh / November 22, 2024 at 3:25 PM
The Senate Judiciary Committee on Thursday (Nov. 21) voted 11-10 to pass an amended version of S. 2220, the Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act, that aims to update mechanisms used by the Patent and Trademark Office’s Patent Trial and Appeal Board (PTAB) to adjudicate patent validity without preventing patient advocacy groups or generic drug makers from challenging patents, but further revisions to the bill are possible. Several lawmakers who voted for the bill argued the...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.